I. Jensen
- Genetics top 10%
- Neurogenetic and Muscular Disorders Research 6
-
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 4
- Diabetes Management and Research 3
-
- Antimicrobial Resistance in Staphylococcus 4
-
- Breast Cancer Treatment Studies 4
-
- CRISPR and Genetic Engineering 3
-
- Radiation Therapy and Dosimetry 3
-
- Bacterial Identification and Susceptibility Testing 3
- Co-authors
- Aa. VølundLise G. HedïngW. FalholtK. FalholtHenrik B. MortensenS L JensenOmar DabbousB. Maru
- Partner nations
- United StatesDenmarkUnited Kingdom
In The Last Decade
I. Jensen
39 papers receiving 484 citations
Peers
Comparison fields: 5 of 78
- Genetics 81
- Endocrinology, Diabetes and Metabolism 123
- Applied Microbiology and Biotechnology 13
- Physiology 94
- Surgery 146
Countries citing papers authored by I. Jensen
This map shows the geographic impact of I. Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Jensen more than expected).
Fields of papers citing papers by I. Jensen
This network shows the impact of papers produced by I. Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Jensen. The network helps show where I. Jensen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside I. Jensen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2021 | 3 | |
| 4 | 2020 | 3 | |
| 5 | 2020 | 10 | |
| 6 | 2019 | 1 | |
| 7 | 2019 | 2 | |
| 8 | 2019 | 5 | |
| 9 | 2019 | 1 | |
| 10 | 2019 | 1 | |
| 11 | Budget Impact Analysis of Using Daunorubicin-Cytarabine Liposome in Patients with Newly Diagnosed Therapy-Related AML or AML and Myelodysplasia-Related Changes. | 2018 | 7 |
| 12 | 2017 | 1 | |
| 13 | 2017 | 0 | |
| 14 | 2016 | 20 | |
| 15 | 2015 | 16 | |
| 16 | 2015 | 3 | |
| 17 | 2014 | 0 | |
| 18 | 2000 | 12 | |
| 19 | 1991 | 60 | |
| 20 | 1988 | 93 |
About I. Jensen
I. Jensen is a scholar working on Applied Microbiology and Biotechnology, Genetics, Family Practice, Clinical Biochemistry and Cancer Research, having authored 45 papers that have together received 510 indexed citations. Recurring topics across this work include Neurogenetic and Muscular Disorders Research (6 papers), Antimicrobial Resistance in Staphylococcus (4 papers), Breast Cancer Treatment Studies (4 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (4 papers), Diabetes Management and Research (3 papers), CRISPR and Genetic Engineering (3 papers), Radiation Therapy and Dosimetry (3 papers) and Bacterial Identification and Susceptibility Testing (3 papers). The work is most often cited by research in Genetics (81 citations), Endocrinology, Diabetes and Metabolism (123 citations), Applied Microbiology and Biotechnology (13 citations), Physiology (94 citations) and Surgery (146 citations). I. Jensen has collaborated with scholars based in United States, Denmark and United Kingdom. Frequent co-authors include Aa. Vølund, Lise G. Hedïng, W. Falholt, K. Falholt, Henrik B. Mortensen, S L Jensen, Omar Dabbous, B. Maru, Douglas E. Feltner and Daniel C. Malone. Their work appears in journals such as Value in Health, Radiotherapy and Oncology, Diabetic Medicine, Blood and Journal of Managed Care & Specialty Pharmacy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.